They Just Don't Get...
Health Care: Drugs
Accelr8 Technology Corporation (AXK: AMEX)
$1.36 -0.06 | -4.23%
02/09/12 - 03:35 PM ET
10.85K / 37.40K
Vol / Avg. Vol:1.38 / 1.42
Open / Prev. Close:1.36 - 1.45
Today's Range:1.02 - 7.80
52 Wk Range:17.36%
Performance YTD:TheStreet Rating:
Portfolios with AXK
- Portfolio NameUser Type
- ContributorBest-Performing Stocks Unde...
- Contributor10 Best-Performing Stocks U...
- Contributor10 Best-Performing Stocks U...
- UserMary
- UserBerridge Investments
- Userlaredo Portfolio 1
- Usergenomiks BIOMED
- UserPANTERA GROUP 169(SUPRATRADE)
- UserBenitrans GStock II
- UserCharles
Latest AXK Headlines from TheStreet
- Accelr8 Technology Corporation Stock Downgraded (AXK) 11.02.11 | 07:11 am
- Accelr8 Technology Stock Soars (AXK) 10.12.11 | 10:10 am
- Accelr8 Technology Stock Soars (AXK) 10.05.11 | 02:10 pm
- Best-Performing Stocks Under $5 in 2011 09.28.11 | 01:09 pm
- Best-Performing Stocks Under $5 in 2011 08.31.11 | 06:08 am
- Accelr8 Technology Stock Gaps Up On Today's Open (AXK) 06.30.11 | 10:06 am
- Accelr8 Technology Stock Soars (AXK) 06.22.11 | 02:06 pm
- Accelr8 Technology Stock Soars (AXK) 06.09.11 | 10:06 am
- 10 Best-Performing Stocks Under $5 This Year 04.27.11 | 06:04 am
- 10 Best-Performing Stocks Under $5 This Year 03.30.11 | 07:03 am
Press Releases for AXK
- Accelr8 Announces Interim Plan And Advanced Studies - Business Wire 10.13.11 | 07:10 am
- Accelr8 Announces Renewal And Expansion Of SCHOTT Microarray License, And Notice Of Allowance For New Patent - Business Wire 09.22.11 | 08:09 am
- Accelr8 Announces Results In Award-Winning Presentation For Rapid Diagnostics With ICU Specimens - Business Wire 09.19.11 | 10:09 am
- Accelr8 Announces Continuation And Expansion Of BACcel™ Development Collaboration - Business Wire 07.25.11 | 08:07 am
- Accelr8 To Receive Award For ICAAC Presentation - Business Wire 07.18.11 | 07:07 am
- Accelr8 Announces Continuation Of BACcel™ Collaboration - Business Wire 06.30.11 | 05:06 pm
- Accelr8 States That Its Policy Is Not To Comment On Unusual Market Activity Or Rumors - Business Wire 06.09.11 | 11:06 am
- Accelr8 4-Hour Test Identifies New Drug-Resistant “Staph” (hVISA) Undetectable By Hospital Labs - Business Wire 05.23.11 | 07:05 am
- Accelr8 States That Its Policy Is Not To Comment On Unusual Market Activity Or Rumors - Business Wire 05.19.11 | 05:05 pm
- Accelr8 Announces Initial Results From ICU Pilot Clinical Study For Same-Day, Multi-Organism, Multi-Resistance Diagnostics Presented At ATS - Business Wire 05.17.11 | 07:05 am
Partner Headlines for AXK
- Accelr8 Technology Corp: Invest At Your Own Risk - Seeking Alpha 06.24.11 | 09:06 am
